First Tracks Biotherapeutics, Inc. TRAX
Set alert
45.08 USD -0.15 -0.32%
At close · Oct 30
46.60 +1.52 +3.37%
After hours · Oct 30, 4:43 PM ET
43.36 Day range 45.87
15.32 52-week range 47.92
- YTD
- +137.26%
- 1 year
- +137.26%
- Open
- 45.03
- Prev close
- 45.23
- Mkt cap
- 1.89B
- Vol
- 434.20K
- Avg vol
- 827.18K
- EPS
- -4.71
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 43.36
- High
- 45.87
- Forward P/E
- -12.45
- Beta
- 0.00
- Short ratio
- 6.01
- Inst. own
- 88.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 38.86
- 200-d avg
- 30.42
- 1y target
- 74.17
Financial health
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -4.0×
FY 2023 5y median -4.0× FY 2025
P/S 0.0×
FY 2023 5y median 0.0× FY 2025
P/B 2.3×
FY 2023 5y median 1.7× FY 2025
P/FCF -4.6×
FY 2023 5y median -5.2× FY 2025
EV/EBITDA -2.5×
FY 2023 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2023 5y median 0.0× FY 2025
FCF Yield -21.7%
FY 2023 5y median -19.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2023 5y median 0.0% FY 2025
ROE -57.8%
FY 2023 5y median -41.8% FY 2025
ROIC -59.4%
FY 2023 5y median -44.4% FY 2025
ROA -50.2%
FY 2023 5y median -37.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2023 FY 2025
Operating Income 1.2%
FY 2023 FY 2025
EPS (diluted) 0.0%
FY 2023 FY 2025
Free Cash Flow -13.4%
FY 2023 FY 2025
Financial Health
Current Ratio 10.2×
FY 2023 5y median 10.8× FY 2025
Quick Ratio 10.2×
FY 2023 5y median 10.8× FY 2025
Debt / Equity 0.0×
FY 2023 5y median 0.0× FY 2025
Net Debt / EBITDA 1.3×
FY 2023 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2023 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31